Literature DB >> 21669181

Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis.

Robert A Copeland1, Aravind Basavapathruni, Mikel Moyer, Margaret Porter Scott.   

Abstract

Jump dilution analysis is commonly used to evaluate the reversibility of inhibition and to quantify the residence time of the inhibitor-enzyme complex. During hit and lead characterization, one sometimes observes apparently linear progress curves after jump dilution that display activity recoveries that are intermediate between those expected for fully reversible and irreversible inhibition. Computer simulations of progress curves after jump dilution indicate that seemingly linear progress curves can result when dealing with tight-binding inhibitors if substoichiometric concentrations of inhibitor are preincubated with enzyme. In this situation, the activity recovered is comparable to that expected for instantaneously reversible inhibitors. In addition, simulations demonstrate that intermediate values of activity recovery may be observed for compounds with modestly slow dissociation rates (i.e., residence times >0min but ≤20min) when the attending curvature of the data is not accounted for. The observation of intermediate values of recovery can, thus, serve as an indication of either modest residence time or a contaminating inactivator within an inhibitor sample, in either case prompting greater scrutiny of the test compound.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669181     DOI: 10.1016/j.ab.2011.05.029

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  33 in total

1.  Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.

Authors:  Behnoush Hajian; Eric Scocchera; Carolyn Shoen; Jolanta Krucinska; Kishore Viswanathan; Narendran G-Dayanandan; Heidi Erlandsen; Alexavier Estrada; Katarína Mikušová; Jana Korduláková; Michael Cynamon; Dennis Wright
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

2.  Oxanosine Monophosphate Is a Covalent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase.

Authors:  Runhan Yu; Youngchang Kim; Natalia Maltseva; Philip Braunstein; Andrzej Joachimiak; Lizbeth Hedstrom
Journal:  Chem Res Toxicol       Date:  2019-02-25       Impact factor: 3.739

3.  A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors.

Authors:  Weixuan Yu; Carla Neckles; Andrew Chang; Gopal Reddy Bommineni; Lauren Spagnuolo; Zhuo Zhang; Nina Liu; Christina Lai; James Truglio; Peter J Tonge
Journal:  Anal Biochem       Date:  2015-02-14       Impact factor: 3.365

Review 4.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

5.  Translating slow-binding inhibition kinetics into cellular and in vivo effects.

Authors:  Grant K Walkup; Zhiping You; Philip L Ross; Eleanor K H Allen; Fereidoon Daryaee; Michael R Hale; John O'Donnell; David E Ehmann; Virna J A Schuck; Ed T Buurman; Allison L Choy; Laurel Hajec; Kerry Murphy-Benenato; Valerie Marone; Sara A Patey; Lena A Grosser; Michele Johnstone; Stephen G Walker; Peter J Tonge; Stewart L Fisher
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

6.  Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Authors:  Yohannes T Ghebremariam; Paea LePendu; Jerry C Lee; Daniel A Erlanson; Anna Slaviero; Nigam H Shah; James Leiper; John P Cooke
Journal:  Circulation       Date:  2013-07-03       Impact factor: 29.690

7.  A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice.

Authors:  Mar Cuadrado-Tejedor; Carolina Garcia-Barroso; Juan A Sánchez-Arias; Obdulia Rabal; Marta Pérez-González; Sara Mederos; Ana Ugarte; Rafael Franco; Victor Segura; Gertrudis Perea; Julen Oyarzabal; Ana Garcia-Osta
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

8.  Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton.

Authors:  Zhen Chen; Wakana Mori; Xiaoyun Deng; Ran Cheng; Daisuke Ogasawara; Genwei Zhang; Michael A Schafroth; Kenneth Dahl; Hualong Fu; Akiko Hatori; Tuo Shao; Yiding Zhang; Tomoteru Yamasaki; Xiaofei Zhang; Jian Rong; Qingzhen Yu; Kuan Hu; Masayuki Fujinaga; Lin Xie; Katsushi Kumata; Yuancheng Gou; Jingjin Chen; Shuyin Gu; Liang Bao; Lu Wang; Thomas Lee Collier; Neil Vasdev; Yihan Shao; Jun-An Ma; Benjamin F Cravatt; Christopher Fowler; Lee Josephson; Ming-Rong Zhang; Steven H Liang
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

9.  Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.

Authors:  Samantha N Muellers; Juliana A Gonzalez; Abinash Kaur; Vital Sapojnikov; Annie Laurie Benzie; Dean G Brown; David W Parkin; Brian J Stockman
Journal:  ACS Infect Dis       Date:  2019-02-01       Impact factor: 5.084

10.  Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.

Authors:  Andrew Chang; Johannes Schiebel; Weixuan Yu; Gopal R Bommineni; Pan Pan; Michael V Baxter; Avinash Khanna; Christoph A Sotriffer; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2013-06-06       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.